333 related articles for article (PubMed ID: 33999717)
1. Does the application of acetylcholinesterase inhibitors in the treatment of Alzheimer's disease lead to depression?
Mitić M; Lazarević-Pašti T
Expert Opin Drug Metab Toxicol; 2021 Jul; 17(7):841-856. PubMed ID: 33999717
[No Abstract] [Full Text] [Related]
2. Modulators of Acetylcholinesterase Activity: From Alzheimer's Disease to Anti-Cancer Drugs.
Lazarevic-Pasti T; Leskovac A; Momic T; Petrovic S; Vasic V
Curr Med Chem; 2017; 24(30):3283-3309. PubMed ID: 28685687
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in acetylcholinesterase Inhibitors and Reactivators: an update on the patent literature (2012-2015).
McHardy SF; Wang HL; McCowen SV; Valdez MC
Expert Opin Ther Pat; 2017 Apr; 27(4):455-476. PubMed ID: 27967267
[TBL] [Abstract][Full Text] [Related]
4. Acetylcholinesterase inhibitors: a patent review (2008 - present).
Pohanka M
Expert Opin Ther Pat; 2012 Aug; 22(8):871-86. PubMed ID: 22768972
[TBL] [Abstract][Full Text] [Related]
5. Is there a rationale for the use of acetylcholinesterase inhibitors in the therapy of Alzheimer's disease?
Benzi G; Moretti A
Eur J Pharmacol; 1998 Apr; 346(1):1-13. PubMed ID: 9617746
[TBL] [Abstract][Full Text] [Related]
6. Old and new acetylcholinesterase inhibitors for Alzheimer's disease.
Galimberti D; Scarpini E
Expert Opin Investig Drugs; 2016 Oct; 25(10):1181-7. PubMed ID: 27459153
[TBL] [Abstract][Full Text] [Related]
7. Acetylcholinesterase inhibitors as Alzheimer therapy: from nerve toxins to neuroprotection.
Singh M; Kaur M; Kukreja H; Chugh R; Silakari O; Singh D
Eur J Med Chem; 2013; 70():165-88. PubMed ID: 24148993
[TBL] [Abstract][Full Text] [Related]
8. Cholinesterase inhibitors: a patent review (2007 - 2011).
de los Ríos C
Expert Opin Ther Pat; 2012 Aug; 22(8):853-69. PubMed ID: 22764681
[TBL] [Abstract][Full Text] [Related]
9. Naturally Occurring Cholinesterase Inhibitors from Plants, Fungi, Algae, and Animals: A Review of the Most Effective Inhibitors Reported in 2012-2022.
Murray AP; Biscussi B; Cavallaro V; Donozo M; Rodriguez SA
Curr Neuropharmacol; 2024; 22(10):1621-1649. PubMed ID: 37357520
[TBL] [Abstract][Full Text] [Related]
10. Cholinesterase inhibitors used in the treatment of Alzheimer's disease: the relationship between pharmacological effects and clinical efficacy.
Wilkinson DG; Francis PT; Schwam E; Payne-Parrish J
Drugs Aging; 2004; 21(7):453-78. PubMed ID: 15132713
[TBL] [Abstract][Full Text] [Related]
11. Current concepts on selected plant secondary metabolites with promising inhibitory effects against enzymes linked to Alzheimer's disease.
Orhan IE
Curr Med Chem; 2012; 19(14):2252-61. PubMed ID: 22414107
[TBL] [Abstract][Full Text] [Related]
12. Molecular modeling, docking and ADMET studies applied to the design of a novel hybrid for treatment of Alzheimer's disease.
da Silva CH; Campo VL; Carvalho I; Taft CA
J Mol Graph Model; 2006 Oct; 25(2):169-75. PubMed ID: 16413803
[TBL] [Abstract][Full Text] [Related]
13. Cholinesterase Inhibitors for Alzheimer's Disease: Multitargeting Strategy Based on Anti-Alzheimer's Drugs Repositioning.
Kabir MT; Uddin MS; Begum MM; Thangapandiyan S; Rahman MS; Aleya L; Mathew B; Ahmed M; Barreto GE; Ashraf GM
Curr Pharm Des; 2019; 25(33):3519-3535. PubMed ID: 31593530
[TBL] [Abstract][Full Text] [Related]
14. Potent Acetylcholinesterase Inhibitors: Potential Drugs for Alzheimer's Disease.
Akıncıoğlu H; Gülçin İ
Mini Rev Med Chem; 2020; 20(8):703-715. PubMed ID: 31902355
[TBL] [Abstract][Full Text] [Related]
15. Cholinesterase inhibition in Alzheimer's disease: is specificity the answer?
Macdonald IR; Rockwood K; Martin E; Darvesh S
J Alzheimers Dis; 2014; 42(2):379-84. PubMed ID: 24898642
[TBL] [Abstract][Full Text] [Related]
16. Possibility of Acetylcholinesterase Overexpression in Alzheimer Disease Patients after Therapy with Acetylcholinesterase Inhibitors.
Kračmarová A; Drtinová L; Pohanka M
Acta Medica (Hradec Kralove); 2015; 58(2):37-42. PubMed ID: 26455564
[TBL] [Abstract][Full Text] [Related]
17. Butyrylcholinesterase: an important new target in Alzheimer's disease therapy.
Greig NH; Lahiri DK; Sambamurti K
Int Psychogeriatr; 2002; 14 Suppl 1():77-91. PubMed ID: 12636181
[TBL] [Abstract][Full Text] [Related]
18. Pharmacodynamic-tolerability relationships of cholinesterase inhibitors for Alzheimer's disease.
Imbimbo BP
CNS Drugs; 2001; 15(5):375-90. PubMed ID: 11475943
[TBL] [Abstract][Full Text] [Related]
19. Acetylcholinesterase in Alzheimer's disease.
Talesa VN
Mech Ageing Dev; 2001 Nov; 122(16):1961-9. PubMed ID: 11589914
[TBL] [Abstract][Full Text] [Related]
20. In Silico Analysis of Green Tea Polyphenols as Inhibitors of AChE and BChE Enzymes in Alzheimer's Disease Treatment.
Ali B; Jamal QM; Shams S; Al-Wabel NA; Siddiqui MU; Alzohairy MA; Al Karaawi MA; Kesari KK; Mushtaq G; Kamal MA
CNS Neurol Disord Drug Targets; 2016; 15(5):624-8. PubMed ID: 26996169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]